ArticleGland surgery2026
Multicavity gas migration following da Vinci 5 transoral robotic thyroidectomy in a 50-year-old male: a case report of successful conservative management.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Transoral robotic thyroidectomy (TORT) relies on continuous carbon dioxide (CO Case Description: A 50-year-old male with papillary thyroid carcinoma (PTC) of the left thyroid lobe underwent transoral robotic left hemithyroidectomy with central lymph node dissection using the DV5 system. Insufflation was maintained at 8 mmHg with a flow rate of 20 L/min; the procedure was uneventful. Upon post-anesthesia care unit (PACU) admission, the patient was stable (SpO Conclusions: Extensive multicavitary gas migration can occur following TORT even under standard insufflation settings and without direct organ injury. The DV5's integrated airflow regulation may alter intraoperative pressure gradients in way that differ from prior platforms. Surgeons adopting DV5 for TORT should consider reducing insufflation pressure to 6 mmHg, restricting automated smoke evacuation during deep dissection, and extending PACU monitoring for at least 60 minutes post-extubation. Multidisciplinary collaboration with system specialists is essential during platform adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.